全文获取类型
收费全文 | 4788篇 |
免费 | 475篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 165篇 |
儿科学 | 267篇 |
妇产科学 | 131篇 |
基础医学 | 578篇 |
口腔科学 | 130篇 |
临床医学 | 529篇 |
内科学 | 813篇 |
皮肤病学 | 55篇 |
神经病学 | 380篇 |
特种医学 | 178篇 |
外科学 | 759篇 |
综合类 | 209篇 |
预防医学 | 431篇 |
眼科学 | 169篇 |
药学 | 304篇 |
中国医学 | 2篇 |
肿瘤学 | 175篇 |
出版年
2021年 | 71篇 |
2020年 | 48篇 |
2019年 | 91篇 |
2018年 | 95篇 |
2017年 | 74篇 |
2016年 | 70篇 |
2015年 | 87篇 |
2014年 | 106篇 |
2013年 | 155篇 |
2012年 | 221篇 |
2011年 | 232篇 |
2010年 | 131篇 |
2009年 | 142篇 |
2008年 | 229篇 |
2007年 | 207篇 |
2006年 | 231篇 |
2005年 | 198篇 |
2004年 | 188篇 |
2003年 | 169篇 |
2002年 | 168篇 |
2001年 | 168篇 |
2000年 | 185篇 |
1999年 | 161篇 |
1998年 | 65篇 |
1997年 | 57篇 |
1996年 | 71篇 |
1995年 | 45篇 |
1994年 | 52篇 |
1993年 | 45篇 |
1992年 | 109篇 |
1991年 | 92篇 |
1990年 | 88篇 |
1989年 | 88篇 |
1988年 | 80篇 |
1987年 | 76篇 |
1986年 | 85篇 |
1985年 | 85篇 |
1984年 | 69篇 |
1983年 | 51篇 |
1982年 | 51篇 |
1981年 | 37篇 |
1980年 | 31篇 |
1979年 | 46篇 |
1978年 | 41篇 |
1977年 | 38篇 |
1976年 | 34篇 |
1975年 | 45篇 |
1974年 | 42篇 |
1973年 | 32篇 |
1968年 | 44篇 |
排序方式: 共有5275条查询结果,搜索用时 968 毫秒
31.
32.
Accumulation of arsenic and zinc in the rhizosphere of wetland plants 总被引:12,自引:0,他引:12
33.
Vivek N Ahya Alden M Doyle James D Mendez David A Lipson Jason D Christie Emily A Blumberg Alberto Pochettino Linda Nelson Roy D Bloom Robert M Kotloff 《The Journal of heart and lung transplantation》2005,24(7):932-935
Chronic rejection is the major hurdle to long-term survival after lung transplantation. Endobronchial infection with Pseudomonas aeruginosa is common in patients with chronic rejection and this may further contribute to deterioration of the allograft. Inhaled tobramycin is commonly used to treat P aeruginosa airways infection in patients with cystic fibrosis. The safety of inhaled tobramycin in transplant recipients, however, has not been established. We describe the first report of a lung transplant recipient who developed renal failure and vestibular injury after receiving inhaled tobramycin. We review the literature regarding the safety of inhaled tobramycin and discuss potential mechanisms that may promote systemic toxicity in transplant recipients. 相似文献
34.
Ingi Lee Todd D. Barton Simin Goral Alden M. Doyle Roy D. Bloom Donna Chojnowski Kathleen Korenda Emily A. Blumberg 《American journal of transplantation》2005,5(11):2791-2795
Dapsone, used for prevention of Pneumocystis jirovecii infections, has been reported to cause hemolytic anemia and methemoglobinemia; its tolerability in solid organ transplant recipients is not well described. We investigated dapsone-related adverse events in patients undergoing solid organ transplantation from 1999 to 2004. Transplant providers identified patients for the investigators who then reviewed the patients' hospital and outpatient records. Sixteen solid organ transplant recipients fit case definitions for dapsone-related hemolytic anemia (n = 11) or methemoglobinemia (n = 5). Median time from event to dapsone discontinuation was 15 days; all patients improved after drug discontinuation. G6PD enzyme activity was normal in all patients whose test results were available. Dapsone may be associated with hemolytic anemia or methemoglobinemia, even with normal G6PD levels. These events are often not promptly recognized, and drug discontinuation is delayed. Dapsone-related hemolytic anemia or methemoglobinemia should be considered in solid organ transplant recipients with unexplained anemia or hypoxia. 相似文献
35.
Having read the introduction, I had high hopes for this secondedition of the Anaesthetic Aide Memoire. Not too weighty andof a size that would fit into the pocket of a white coat (ormore appropriately theatre blues). In their introduction, theauthors set out their stall by saying it is a compilation oflists and diagrams to be used as a ready reference for bothsenior trainees and consultants. They see it as a useful aidto teaching and 相似文献
36.
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. 总被引:1,自引:0,他引:1 下载免费PDF全文
S Todo J J Fung T E Starzl A Tzakis H Doyle K Abu-Elmagd A Jain R Selby O Bronsther W Marsh et al. 《Annals of surgery》1994,220(3):297-309
OBJECTIVE: The efficacy for primary orthotopic liver transplantation of a new immunosuppressive agent, FK 506 (tacrolimus, Prograf, Fujisawa USA, Deerfield, IL), was determined. SUMMARY BACKGROUND DATA: After 3 years of preclinical research, a clinical trial of FK 506 for orthotopic liver transplantation was begun in February 1989, first as a rescue therapy for patients with intractable rejection with conventional immunosuppression, then as a primary drug. METHODS: Between August 1989 and December 1993, 1391 recipients (1188 adult and 203 pediatric) of primary liver allografts were treated with FK 506 from the outset. Results from these patients were analyzed and compared with those of 1212 historical control patients (971 adult and 241 pediatric) given cyclosporine-based immunosuppression. RESULTS: Actuarial survival at 4 years was 86.2% with FK 506 versus 65.5% with cyclosporine in the pediatric patients (p < 0.0000) and 71.4% versus 65.5% in the adults (p < 0.0005). The need for retransplantation was reduced significantly for FK 506 patients. Four-year graft survival was 77.0% with FK 506 versus 48.4% with cyclosporine in the pediatric patients (p < 0.0000), and 61.9% with FK 506 versus 51.4% with cyclosporine in the adult recipients (p < 0.0000). Regression analysis revealed that reduction in mortality or graft loss from uncontrollable rejection, sepsis, technical failure, and recurrent original liver disease were responsible for the improved results with FK 506 therapy. CONCLUSIONS: FK 506 is a potent and superior immunosuppressive agent for orthotopic liver transplantation. 相似文献
37.
Selective laser trabeculoplasty in phakic and pseudophakic eyes. 总被引:2,自引:0,他引:2
BACKGROUND AND OBJECTIVE: To evaluate the effect of pseudophakia on the success of selective laser trabeculoplasty in lowering intraocular pressure (IOP). PATIENTS AND METHODS: In this retrospective, nonrandomized clinical trial, a chart review of all patients who underwent selective laser trabeculoplasty from September 2002 to June 2004 using a frequency-doubled Q-switched 532-nm Nd:YAG laser was performed. Changes in IOP and statistical significance were determined at each follow-up period. Average decrease in IOP and success rates for phakic and pseudophakic eyes were compared statistically at each time period. RESULTS: In the phakic group, mean IOP decreased from 18.1 to 15.5 mm Hg (P < .0005) and mean glaucoma medication use decreased from 2.1 to 1.6 medications after 24 months of follow-up. In the pseudophakic group, mean IOP decreased from 18.3 to 15.2 mm Hg (P < .005) and mean glaucoma medication use decreased from 2.2 to 1.6 medications. Success rates ranged from 54% to 67% in the phakic group and 52% to 65% in the pseudophakic group. No statistically significant difference between phakic and pseudophakic eyes in decreased IOP or success rates was seen at any time point (P > .05). No significant complications occurred in either group. CONCLUSIONS: Selective laser trabeculoplasty is effective in lowering IOP in both phakic and pseudophakic patients. 相似文献
38.
S B Harrap J A Nicolaci A E Doyle 《Clinical and experimental pharmacology & physiology》1986,13(11-12):753-765
Spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats aged 4 and 16 weeks were given an acute oral dose of either Perindopril (3 mg/kg) or vehicle. Direct blood pressure (BP), glomerular filtration rate (GFR) and renal blood flow (RBF) were measured, and renal vascular resistance (RVR) calculated. GFR and RBF were lower in vehicle-treated SHR than WKY at 4 weeks of age, but were not different at 16 weeks. Acute Perindopril increased GFR and RBF and reduced RVR in both strains at both 4 and 16 weeks. Total body sodium, sodium intake and blood pressure were measured in SHR and WKY from 1 to 28 weeks of age. Rats of both strains were treated daily between 4 and 16 weeks of age with either Perindopril (3 mg/kg per day) or vehicle. Chronic Perindopril treatment prevented the development of hypertension in the SHR. From 16 to 28 weeks of age, after stopping Perindopril, BP rose slowly in SHR, but remained lower than vehicle-treated SHR. No changes in total body sodium occurred during Perindopril treatment. GFR and RBF were measured in SHR and WKY chronically treated with either Perindopril or vehicle, 3 days or 12 weeks after stopping treatment. In WKY, GFR and RBF were not different between Perindopril-treated and untreated rats at either measurement. In SHR, GFR and RBF remained significantly higher in rats previously treated with Perindopril at both ages. These findings suggest that renal haemodynamic abnormalities may be important in the initiation of hypertension in the SHR. These renal circulatory abnormalities and the hypertension of the SHR depend, at least in part, on intact converting enzyme activity, yet appear to be independent of abnormalities of total body sodium. At a later age, hypertension seems to develop independently of renal vascular abnormalities. 相似文献
39.
D J Doyle 《Journal of clinical anesthesia》1990,2(5):324-325
A 42-year-old woman taking tranylcypromine, a monoamine oxidase (MAO) inhibitor, was hypovolemic from a ruptured ectopic pregnancy and required an emergency laparotomy. Anesthetic induction with ketamine, an agent with sympathomimetic properties, was used because of her hypovolemia, despite theoretical concerns of precipitating an adrenergic crisis. The patient's hemodynamic course remained unchanged with induction and intubation, and with further fluid and blood administration, satisfactory hemodynamic conditions were obtained. This report is believed to be the first to describe the use of ketamine in a patient taking MAO inhibitors. 相似文献
40.
L Doyle 《Journal of the Royal Society of Medicine》1988,81(12):729-731